IAccumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

Keyphrases

• Micafungin 100%
• Fungal Diseases 100%
• Safety Data 100%
• Elderly Adults 33%
• Clinical Safety 33%
• Safety Profile 33%
• Treatment-related Adverse Events 33%
• Efficacy Study 16%
• Safety Study 16%
• Clinical Efficacy 16%
• Malignancy 16%
• Diarrhea 16%
• Pediatric Patients 16%
• Transplantation 16%
• High Dose 16%
• Hematopoietic Stem Cells 16%
• Treatment Duration 16%
• Renal Impairment 16%
• Elderly Patients 16%
• Clinical Trial Data 16%
• Incidence Rate 16%
• Adverse Events 16%
• Echinocandins 16%
• Fever 16%
• High Incidence 16%
• Alkaline Phosphatase 16%
• Nausea 16%
• Increased Incidence 16%
• Vomiting 16%
• Aspartate Aminotransferase 16%
• Hypokalemia 16%
• Alanine Aminotransferase 16%
• Large Database 16%
• Pyrexia 16%
• Phlebitis 16%
• Adverse Event Data 16%
• Medical Dictionary for Regulatory Activities (MedDRA) 16%
• One Dose 16%
• Clinical Trial Safety 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Micafungin 100%
• Adverse Event 66%
• Clinical Trial 33%
• HIV 16%
• Diarrhea 16%
• Nausea 16%
• Fever 16%
• Aspartate Aminotransferase 16%
• Alanine Aminotransferase 16%
• Hypokalemia 16%
• Alkaline Phosphatase 16%
• Phlebitis 16%
• MedDRA 16%
• Echinocandin 16%